by ComplianceQuest

My Dashboard Inspection Tracker FDA Guidance Templates Assessments

Sign in Get started

Tracker Overview Enforcement Themes Form 483s Warning Letters Inspections Recalls Investigators Companies Facilities

ANALYTICS

Tracker Overview Enforcement Themes

FDA ACTIONS

Form 483s Warning Letters Inspections Recalls

AUDIT READINESS

COMPANIES

Companies Facilities

Loading…

Dashboard Warning LettersWarning Letter Details

Laboratorios Jaloma S.A. de C.V. Warning Letter Details

Warning Letter

Laboratorios Jaloma S.A. de C.V.

Calle Emiliano Zapata, No. 422 Oblatos 44380 Guadalajara , Jal. Mexico

Issue DateMay 22, 2026

FEI Number3002600322

Violations5

CountryMexico

Issuing Office

Center for Drug Evaluation and Research (CDER)

Product Type

Drugs

Status

Open

Subject

CGMP/OTC/Finished Pharmaceuticals/Adulterated

Laboratorios Jaloma S.A. de C.V. FDA Warning Letter, May 22, 2026